¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Adv Cyclic Nucleotide Res"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diphosphopyridine nucleotide
    ÀÌÀλêÇǸ®µò´ºÅ¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • single nucleotide polymorphism
    ´ÜÀÏ´ºÅ¬·¹¿ÀƼµå´ÙÇüÅÂ
  • cyclic
    ÁÖ±â-, ¼øÈ¯-, ȸ·Î-, °í¸®-
  • cyclic adenosine monophosphate
    °í¸®ÇüAMP
  • cyclic bleeding
    ÁÖ±âÃâÇ÷
  • cyclic compound
    °í¸®È­ÇÕ¹°
  • cyclic fluctuation
    ÁÖ±âÀûº¯µ¿
  • cyclic frequency
    ÁÖ±âÁ֯ļö
  • cyclic hematopoiesis
    Áֱ⼺Á¶Ç÷
  • cyclic hemorrhage
    ÁÖ±âÃâÇ÷
  • cyclic hydrocarbon
    °í¸®ÅºÈ­¼ö¼Ò
  • cyclic neutropenia
    ÁÖ±âÁß¼º±¸°¨¼Ò(Áõ)
  • cyclic parturition
    ÁÖ±âºÐ¸¸
  • cyclic periodicity
    ¼øÈ¯Áֱ⼺
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complementary nucleotide
    »óº¸´ºÅ¬·¹¿ÀƼµå
  • diphosphopyridine nucleotide
    ÀÌÀλêÇǸ®µò´ºÅ¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • cyclic bleeding
    ÁÖ±âÃâÇ÷
  • cyclic
    ÁÖ±â-, ¼øÈ¯-, ȸ·Î-, °í¸®-
  • cyclic adenosine monophosphate
    °í¸®¿¡ÀÌ¿¥ÇÇ
  • cyclic compound
    (¢¡closed chain) ´ÝÈù»ç½½
  • cyclic ester
    °í¸®Çü¿¡½ºÅ׸£
  • cyclic fluctuation
    ¼øÈ¯º¯È­
  • cyclic frequency
    ÁÖ±âÁ֯ļö
  • cyclic hematopoiesis
    Áֱ⼺Á¶Ç÷
  • cyclic hemorrhage
    ÁÖ±âÃâÇ÷
  • cyclic hydrocarbon
    °í¸®Çüźȭ¼ö¼Ò
  • cyclic neutropenia
    ÁÖ±âÈ£Áß¼º¹éÇ÷±¸°¨¼ÒÁõ
  • cyclic parturition
    ÁÖ±âºÐ¸¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • RES=£¾reticuloendothelial system
    ¼¼¸Á³»Çǰ³, ¸Á³»°è.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cyclic AMP ; cyclic adenosine mono pho sph ate
    °í¸®¸ð¾ç AMP.¾à¸®È¯ ½Ä±¸¾Æ³ë½Å¸ð³ëÆ÷½ºÆäÀÌÆ®, »çÀÌŬ¸¯AMP, cAMP cyclic aclenosine 3 , 5 monophate
  • disease, M ni res
    ¸Þ´Ï¿¡¸£º´
  • reticuloendothelial system =res
    ¼¼¸Á³»Çǰè(á¬ØÑÒ®ù«Í§), ¸Á³»°è(ØÑҮͧ)
  • syndrome, M{0e9}ni{0e8}res
    ¸Þ´Ï¿¡¸£ÁõÈıº
  • diphosphopyridine nucleotide =DPN
    ÀÌÀλêÇǸ®µò ´©Å¬·¹¿ÀƼµå.
  • nicotinamide adenine nucleotide
    ´ÏÄÚÆ¾¾Æ¹Ìµå¾Æµ¥´Ñ´©Å¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀŸÀ̵å
  • nucleotide
    ´©Å¬¸®¿ÀŸÀÌ.
  • triphosphopyridine nucleotide
    »ïÀλêÇǸ®µò´©Å¬·¹¿ÀƼµå.
  • cAMP=>cyclic AMP
    ȯ½ÄAMP
  • cyclic AMP
    °í¸® AMP
  • cyclic AMP-dependent kinase
    °í¸® AMP ÀÇÁ¸¼º Ű³ªÁ¦
  • cyclic GMP
    °í¸® GMP.
  • cyclic adenosin 3-5-phosphate
    °í¸®¾Æµ¥³ë½Å 3-5Àλ꿰.
  • cyclic adenosine monophosphate
    °í¸® AMP
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • RES
    (å²) Reticuloendothelial system
  • "adenosine-3',5'-cyclic monophosphate"
    ¾Æµ¥³ë½Å-3'-5'-°í¸® ÀÏ(ìé)Àλ꿰(×òß«ç¤)
  • cyclic adenylic acid °í¸® ¾Æµ¥´Ñ»ê(ß«)
    "(ÔÒ)(ÔÒ) adenosine-3',5'-cyclic monophosphate,"
  • cyclic AMP receptor protein
    °í¸®AMP ¼ö¿ëü ´Ü¹éÁú(áôé»ô÷Ó±ÛÜòõ)
  • cyclic electron flow
    ¼øÈ¯(âàü») ÀüÀÚ(ï³í­) È帧
  • cyclic GMP
    "°í¸® GMP (ÔÒ) guanosine-3',5'-cyclic monophosphate,"
  • cyclic metabolic pathway
    ȸ·Î ´ë»ç°æ·Î(üÞÖØÓÛÞóÌèÖØ)
  • cyclic peptide
    °í¸®ÆéŸÀ̵å
  • cyclic permutation
    "¼øÈ¯¼ø¿­(âàü»â÷æê), (ÔÒ) circular permutation"
  • cyclic photophosphorylation
    ¼øÈ¯ ±¤ÀλêÈ­(âàü»ÎÃìÝß«ûù)
  • cyclic symmetry
    "°í¸®´ëĪ(Óßöà), (ÔÒ) rotational symmetry"
  • "uanosine-3', 5'-cyclic monophosphate"
    "±¸¾Æ³ë½Å-3`,5'-°í¸® ÀÏÀλê(ìé×òß«)"
  • nucleoside cyclic monophosphate
    °í¸® ÀÏÀλê(ìé×òß«) ´©Å¬¸®¿À»çÀ̵å
  • adenine nucleotide barrier
    ¾Æµ¥´Ñ´©Å¬·¹¿ÀŸÀ̵å À庮(î¡Ûú)
  • block nucleotide
    ºí·Ï ´©Å¬·¹¿ÀŸÀ̵å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cyclic frequency
    ÁÖ±âÁ֯ļö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CNGC cyclic nucleotide gated channel
CNP community nurse practitioner; continuous negative pressure; cranial nerve palsy; 2',3'-cyclic nucleo...
CNPase 2',3'-cyclic nucleotide 3'-phosphohydrolase
ADV adenovirus; adventitia; Aleutian disease virus; Aujeszky disease virus
Adv adenovirus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RES Reserpine
RES Reticulo Endothelial System
CNPase 2',3',cyclic nucleotide-3'-phosphohydrolase
CNP Cyclic nucleotide phosphodiesterase
CNPase 2',3'-Cyclic nucleotide 3'-phosphodiesterase
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 275
    JournalTitle: Advances in cyclic nucleotide research.
    MedAbbr: Adv Cyclic Nucleotide Res
    ISSN: 0084-5930
    ESSN:
    IsoAbbr:
    NlmId: 341362
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Adv. -¿¡ ´ëÇÏ¿©, -¿¡ ¹ÝÇÏ¿©.

    advance

    ÁøÇà, ÀüÀ§ ºÀÇÕÇÏ´Ù
    ÀüÀ§ ºÀÇÕ¼ú, ÀüÀü¼úÀ» ½ÃÇàÇÏ´Ù.
  • nucleotide adenosine triphosphate
    ´ºÅ¬·¹¿ÀƼµå ¾Æµ¥³ë½Å Æ®¸®Æ÷½ºÆäÀÌÆ®
  • cyclic
    Áֱ⼺, ÁÖ±âÀÇ, Áֱ⼺ÀÇ, ¼øÈ¯ÀÇ, °í¸®ÀÇ
    Áֱ⼺ÀÇ, ¼øÈ¯ÀÇ, ȯ»óÀÇ. ÀÌ ¿ë¾î´Â ¿øÀÚÀÇ °í¸®¸¦ ÇÔÀ¯ÇÑ È­ÇÕ¹°¿¡ ´ëÇÏ¿© »ç¿ëµÈ´Ù.
  • cyclic AMP
    ȯ»ó AMP, °í¸®¸ð¾ç AMP, ȯ½Ä ¾Æµ¥³ë½Å ¸ð³ëÆ÷½ºÆäÀÌÆ®, »çÀ̱۸¯ AMP, cAMP
    cyclic adelenosine 3',5'-mono
  • cyclic AMP system
    ȯ»ó AMP °è
  • cyclic condition
    ÁÖ±âÀû »óÅÂ
  • cyclic frequency
    ÁÖ±â Á֯ļö
  • cyclic headache
    Áֱ⼺ µÎÅë
  • cyclic neutropenia
    Áֱ⼺ È£Áß±¸ °¨¼ÒÁõ
    °ñ¼öÀÇ ¼º¼÷ Á¤Áö·Î ÀÎÇÑ Áúº´ÀÌ´Ù. Áõ»óÀÌ ¹«°ú¸³±¸Áõ
  • cyclic spasm
    Áֱ⠿¬Ãà
  • idiopathic cyclic neutropenia
    Ư¹ß¼º Áֱ⼺ È£Áß±¸ °¨¼ÒÁõ
    ¸¸¼ºÇüÀÇ È£Áß±¸ °¨¼ÒÁõÀ¸·Î¼­, ÁÖ±âÀûÀ¸·Î ÀϾ´Â Àç¹ßÀ» Ư¡À¸·Î Çϸç, º´°¨, ¹ß¿­, ±¸³»¿° ¹× °¢Á¾ÀÇ °¨¿°À» µ¿¹ÝÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
RES <abbreviation> Reticuloendothelial system.
(05 Mar 2000)
cyclic nucleotide A nucleoside monophosphate in which the phosphoryl group is linked twice to the sugar moiety; e.g., adenosine 3',5'-cyclic monophosphate (cAMP).
(05 Mar 2000)
cyclic nucleotide-regulated protein kinases <enzyme> A group of enzymes that catalyses the phosphorylation of serine or threonine residues of proteins and is dependent on cyclic nucleotides.
Registry number: EC 2.7.10.-
(12 Dec 1998)
nucleotide 3'-pyrophosphokinase-2',3'-cyclic monophosphokinase <enzyme> Transfers 5'-beta,gamma-pyrophosphate from ATP and some ATP derivatives to nucleotides and nucleosides at the 3'-hydroxyl group; synthesises the respective 3'-pyrophosphoryl nucleotides
Registry number: EC 2.7.6.-
Synonym: ppkase
(26 Jun 1999)
2',3'-cyclic nucleotide 2'-phosphodiesterase <enzyme> Catalyses the hydrolysis of the 2'-phosphodiesterase bond to yield nucleoside 3'phosphate
Registry number: EC 3.1.4.16
Synonym: 2',3'-cyclic nucleotide 2'-phosphohydrolase
(26 Jun 1999)
2',3'-cyclic nucleotide 3'-phosphodiesterase <enzyme> Catalyses the hydrolysis of the 3'-phosphoesterase bond to yield nucleoside 2'-phosphate
Registry number: EC 3.1.4.37
Synonym: 2',3'-cyclic nucleotide 3'-phosphohydrolase, 2',3'-cn phosphodiesterase, 2',3'-cnpase
(26 Jun 1999)
2',3'-cyclic-nucleotide phosphodiesterases <enzyme> Nucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2'- or 3'- phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates.
Registry number: EC 3.1.4.-
(12 Dec 1998)
3',5'-cyclic-nucleotide phosphodiesterase <enzyme> An enzyme that catalyses the hydrolysis of cyclic AMP to form adenosine 5'-phosphate. The enzyme is widely distributed in animal tissue and controls the level of intracellular cyclic AMP. Also acts on 3',5'-cyclic imp and 3',5'-cyclic GMP.
Chemical name: 3',5'-Cyclic-nucleotide 5'-nucleotidohydrolase
Registry number: EC 3.1.4.17
(12 Dec 1998)
adenine nucleotide A condensation product of adenosine and phosphoric acid; a nucleotide found among the hydrolysis products of all nucleic acids. 3'-Adenylic acid (adenosine 3'-monophosphate) and 5'-adenylic acid (adenosine 5'-monophosphate) differ in the place of attachment of the phosphoric acid to the d-ribose; deoxyadenylic acid differs in having H instead of OH at the 2' position of d-ribose.
See: AMP.
Synonym: adenine nucleotide.
(05 Mar 2000)
adenine nucleotide translocase <enzyme> Catalyses the exchange between endogenous and exogenous adenine nucleotides in mitochondria.ec 2.7.7.-.
Registry number: EC 2.7.7.-
(12 Dec 1998)
xanthine nucleotide The monophosphoric ester of xanthosine. An intermediate in GMP biosynthesis.
Synonym: xanthidylic acid, xanthine nucleotide, xanthylic acid.
(05 Mar 2000)
pyrimidine-5'-nucleotide nucleosidase <enzyme> Also acts on some deoxyribonucleotides
Registry number: EC 3.2.2.10
Synonym: pyr-5'-nt-nucleosidase
(26 Jun 1999)
nicotinamide-nucleotide adenylyltransferase <enzyme> An enzyme that catalyses reversibly the transfer of the adenylyl moiety of ATP to the phosphoryl group of nmn to form NAD+ and pyrophosphate. The enzyme is found predominantly in the nuclei and catalyses the final reaction in the major pathway for the biosynthesis of NAD in mammals.
Chemical name: ATP:nicotinamide-nucleotide adenylyltransferase
Registry number: EC 2.7.7.1
(12 Dec 1998)
nucleotide <biochemistry> Phosphate esters of nucleosides. The metabolic precursors of nucleic acids are monoesters with phosphate on carbon 5 of the pentose (known as 5' to distinguish sugar from base numbering).
However many other structures, such as adenosine 3'5' cyclic monophosphate (cAMP) and molecules with 2 or 3 phosphates are also called nucleotides.
(18 Nov 1997)
nucleotide binding fold Protein motif consisting of a fold or pocket with certain conserved residues, required for the binding of nucleotides.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå(ÇÙ»êÀÇ ±¸¼º¼ººÐ)
  • nucleotide sequence
    (»ýÈ­)´ºÅ¬·¹¿ÀƼµå ¹è¿­
  • cyclic adenosine monophosphate
    =CYCLIC AMP
  • cyclic chorus
    À±¹«Ã¢(Dionysus Á¦´Ü µÑ·¹¸¦ µµ´Â)
  • cyclic flower
    À±»ýÈ­
  • cyclic poets
    È£¸Ó¿¡ ÀÌ¾î Æ®·ÎÀÌ ÀüÀïÀ» À¼Àº ½ÃÀεé
  • cyclic,-clical
    ¼øÈ¯±âÀÇ;ÁÖ±âÀûÀÎ;(ÀÏ·ÃÀÇ)»ç½Ã(Àü¼³)ÀÇ;cyclically
  • RES
    reticuloendothelial system
  • in medias res
    »ç°ÇÀÇ Á߽ɿ¡¼­;»ç°Ç µµÁߺÎÅÍ
  • res
    ¹°;½Çü;¹°°Ç;»ç°Ç;Àç»ê
  • res adjudicata
    =RES JUDICATA
  • res gestae
    ÀÌ·ç¾îÁø ÀÏ;¾÷Àû;(¼Ò¼Û»ç°ÇÀÇ)ºÎ´ë»óȲ(Áõ°Å ´É·ÂÀ» °¡Áø Áß¿äÇÑ »ç½Ç)
  • res judicata
    ±â°á »ç°Ç
  • res.
    research;reserve(d);residence;resides;resigned;resistance;resolution
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á